Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study
Details
Age
Adult
Type of Study
Observational
Locations
University of Colorado Hospital
Principal Investigator
John Corboy, MD, MA
Study ID
Protocol Number: 20-2772
More information available at ClinicalTrials.gov: NCT04754542
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers